Microbial Genetics, Interfaculty Institute for Microbiology and Infection Medicine Tübingen (IMIT), University of Tübingen, Tübingen, Germany.
mBio. 2013 Dec 3;4(6):e00976-13. doi: 10.1128/mBio.00976-13.
In their recent article, Hammer et al. (N. D. Hammer, M. L. Reniere, J. E. Cassat, Y. Zhang, A. O. Hirsch, M. Indriati Hood, and E. P. Skaar, mBio 4:e00241-13, 2013) described the dual functions of the two terminal oxidases encoded by cydBA and qoxABCD in Staphylococcus aureus. The aerobic growth of cydB or qoxB single mutant bacteria was barely affected. However, a cydB qoxB double mutant was completely unable to respire and exhibited the small-colony variant phenotype that is typical of menaquinone and heme biosynthesis mutants. The authors found that the two terminal oxidases play a role in pathogenesis. In a systemic mouse infection model, it turned out that in the cydB mutant the bacterial burden was significantly decreased in the heart, kidneys, and liver, while in the qoxB mutant it was decreased only in the liver. These results illustrate that both terminal oxidases contribute to fitness and virulence, representing promising candidates for the development of antimicrobials.
在他们最近的文章中,Hammer 等人(N. D. Hammer、M. L. Reniere、J. E. Cassat、Y. Zhang、A. O. Hirsch、M. Indriati Hood 和 E. P. Skaar,mBio 4:e00241-13, 2013)描述了 cydBA 和 qoxABCD 编码的两个末端氧化酶在金黄色葡萄球菌中的双重功能。cydB 或 qoxB 单突变细菌的需氧生长几乎没有受到影响。然而,cydB qoxB 双突变体完全无法呼吸,并表现出典型的menaquinone 和血红素生物合成突变体的小菌落变异表型。作者发现这两种末端氧化酶在发病机制中发挥作用。在系统性小鼠感染模型中,结果表明 cydB 突变体心脏、肾脏和肝脏中的细菌负荷显著降低,而 qoxB 突变体仅在肝脏中降低。这些结果表明,两种末端氧化酶都有助于适应性和毒力,是开发抗菌药物的有前途的候选物。